![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EIF3F |
Gene summary for EIF3F |
![]() |
Gene information | Species | Human | Gene symbol | EIF3F | Gene ID | 8665 |
Gene name | eukaryotic translation initiation factor 3 subunit F | |
Gene Alias | EIF3S5 | |
Cytomap | 11p15.4 | |
Gene Type | protein-coding | GO ID | GO:0001732 | UniProtAcc | O00303 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
8665 | EIF3F | GSM4909280 | Human | Breast | Precancer | 4.06e-02 | -5.85e-01 | 0.0305 |
8665 | EIF3F | GSM4909287 | Human | Breast | IDC | 1.49e-06 | -3.85e-01 | 0.2057 |
8665 | EIF3F | GSM4909294 | Human | Breast | IDC | 5.17e-10 | -2.40e-01 | 0.2022 |
8665 | EIF3F | GSM4909296 | Human | Breast | IDC | 4.31e-28 | 1.38e-01 | 0.1524 |
8665 | EIF3F | GSM4909297 | Human | Breast | IDC | 1.74e-36 | -2.46e-01 | 0.1517 |
8665 | EIF3F | GSM4909301 | Human | Breast | IDC | 3.14e-06 | -3.45e-01 | 0.1577 |
8665 | EIF3F | GSM4909302 | Human | Breast | IDC | 1.43e-02 | -2.86e-01 | 0.1545 |
8665 | EIF3F | GSM4909305 | Human | Breast | IDC | 4.30e-02 | 2.60e-01 | 0.0436 |
8665 | EIF3F | GSM4909307 | Human | Breast | IDC | 9.14e-03 | 1.07e-01 | 0.1569 |
8665 | EIF3F | GSM4909308 | Human | Breast | IDC | 2.86e-10 | 3.67e-01 | 0.158 |
8665 | EIF3F | GSM4909309 | Human | Breast | IDC | 7.21e-03 | -1.15e-01 | 0.0483 |
8665 | EIF3F | GSM4909311 | Human | Breast | IDC | 6.55e-54 | -4.33e-01 | 0.1534 |
8665 | EIF3F | GSM4909312 | Human | Breast | IDC | 3.28e-38 | 2.96e-01 | 0.1552 |
8665 | EIF3F | GSM4909313 | Human | Breast | IDC | 5.11e-05 | -9.98e-02 | 0.0391 |
8665 | EIF3F | GSM4909315 | Human | Breast | IDC | 6.89e-06 | -3.91e-01 | 0.21 |
8665 | EIF3F | GSM4909316 | Human | Breast | IDC | 9.38e-04 | -4.64e-01 | 0.21 |
8665 | EIF3F | GSM4909319 | Human | Breast | IDC | 1.48e-69 | -5.16e-01 | 0.1563 |
8665 | EIF3F | GSM4909320 | Human | Breast | IDC | 5.97e-06 | -3.73e-01 | 0.1575 |
8665 | EIF3F | GSM4909321 | Human | Breast | IDC | 8.04e-26 | -3.69e-02 | 0.1559 |
8665 | EIF3F | M2 | Human | Breast | IDC | 1.97e-02 | -2.87e-01 | 0.21 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Cervix | N_HPV | ![]() |
Endometrium | AEH | ![]() |
Endometrium | EEC | ![]() |
Prostate | BPH | ![]() |
Prostate | Tumor | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00021819 | Breast | Precancer | cytoplasmic translation | 80/1080 | 148/18723 | 1.59e-59 | 8.54e-56 | 80 |
GO:00226139 | Breast | Precancer | ribonucleoprotein complex biogenesis | 79/1080 | 463/18723 | 2.11e-18 | 1.03e-15 | 79 |
GO:00718269 | Breast | Precancer | ribonucleoprotein complex subunit organization | 48/1080 | 227/18723 | 2.68e-15 | 8.45e-13 | 48 |
GO:00226189 | Breast | Precancer | ribonucleoprotein complex assembly | 47/1080 | 220/18723 | 3.47e-15 | 1.03e-12 | 47 |
GO:00064138 | Breast | Precancer | translational initiation | 30/1080 | 118/18723 | 3.23e-12 | 5.58e-10 | 30 |
GO:00160329 | Breast | Precancer | viral process | 58/1080 | 415/18723 | 3.42e-10 | 3.16e-08 | 58 |
GO:00021838 | Breast | Precancer | cytoplasmic translational initiation | 11/1080 | 34/18723 | 1.87e-06 | 6.63e-05 | 11 |
GO:00017328 | Breast | Precancer | formation of cytoplasmic translation initiation complex | 7/1080 | 16/18723 | 1.50e-05 | 3.71e-04 | 7 |
GO:000218114 | Breast | IDC | cytoplasmic translation | 82/1434 | 148/18723 | 2.60e-52 | 1.48e-48 | 82 |
GO:002261314 | Breast | IDC | ribonucleoprotein complex biogenesis | 83/1434 | 463/18723 | 2.01e-13 | 5.20e-11 | 83 |
GO:007182614 | Breast | IDC | ribonucleoprotein complex subunit organization | 52/1434 | 227/18723 | 5.18e-13 | 1.21e-10 | 52 |
GO:002261814 | Breast | IDC | ribonucleoprotein complex assembly | 51/1434 | 220/18723 | 5.32e-13 | 1.21e-10 | 51 |
GO:001603214 | Breast | IDC | viral process | 75/1434 | 415/18723 | 1.98e-12 | 4.02e-10 | 75 |
GO:000641313 | Breast | IDC | translational initiation | 31/1434 | 118/18723 | 7.29e-10 | 7.52e-08 | 31 |
GO:000218313 | Breast | IDC | cytoplasmic translational initiation | 12/1434 | 34/18723 | 4.35e-06 | 1.53e-04 | 12 |
GO:000173213 | Breast | IDC | formation of cytoplasmic translation initiation complex | 8/1434 | 16/18723 | 8.56e-06 | 2.47e-04 | 8 |
GO:000218124 | Breast | DCIS | cytoplasmic translation | 82/1390 | 148/18723 | 2.21e-53 | 1.25e-49 | 82 |
GO:002261324 | Breast | DCIS | ribonucleoprotein complex biogenesis | 83/1390 | 463/18723 | 3.65e-14 | 1.09e-11 | 83 |
GO:007182624 | Breast | DCIS | ribonucleoprotein complex subunit organization | 52/1390 | 227/18723 | 1.54e-13 | 3.95e-11 | 52 |
GO:002261824 | Breast | DCIS | ribonucleoprotein complex assembly | 51/1390 | 220/18723 | 1.60e-13 | 3.95e-11 | 51 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EIF3F | insertion | Nonsense_Mutation | novel | c.742_743insAGTAAAGTATAGATCCAGGTATATAATTGACATA | p.Gly248GlufsTer2 | p.G248Efs*2 | O00303 | protein_coding | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
EIF3F | SNV | Missense_Mutation | novel | c.317N>G | p.Tyr106Cys | p.Y106C | O00303 | protein_coding | deleterious(0.05) | probably_damaging(0.998) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
EIF3F | SNV | Missense_Mutation | novel | c.941N>G | p.Gln314Arg | p.Q314R | O00303 | protein_coding | tolerated(0.09) | benign(0.268) | TCGA-AA-3845-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
EIF3F | SNV | Missense_Mutation | c.626G>A | p.Gly209Asp | p.G209D | O00303 | protein_coding | tolerated(0.1) | benign(0.01) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
EIF3F | SNV | Missense_Mutation | rs371389618 | c.629N>A | p.Arg210His | p.R210H | O00303 | protein_coding | tolerated(0.24) | benign(0.051) | TCGA-AD-5900-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
EIF3F | SNV | Missense_Mutation | c.833N>A | p.Arg278His | p.R278H | O00303 | protein_coding | tolerated(0.16) | benign(0.01) | TCGA-D5-6924-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
EIF3F | SNV | Missense_Mutation | c.236N>A | p.Gly79Asp | p.G79D | O00303 | protein_coding | tolerated(0.17) | benign(0.027) | TCGA-AG-A002-01 | Colorectum | rectum adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
EIF3F | SNV | Missense_Mutation | c.773N>T | p.Ser258Ile | p.S258I | O00303 | protein_coding | deleterious(0.02) | benign(0.248) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
EIF3F | SNV | Missense_Mutation | novel | c.440N>T | p.Ala147Val | p.A147V | O00303 | protein_coding | tolerated(0.07) | benign(0.141) | TCGA-AP-A1DK-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
EIF3F | SNV | Missense_Mutation | rs200315934 | c.29N>T | p.Ala10Val | p.A10V | O00303 | protein_coding | tolerated_low_confidence(0.3) | benign(0) | TCGA-AP-A1DV-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |